安徽肽渡生物医药科技

Peidu Bio is a Chinese biotechnology company specializing in the research and development of innovative peptide-based therapeutics. The company leverages its proprietary peptide discovery and optimization platform to develop a pipeline focused on metabolic disorders, oncology, and infectious diseases. Key areas of expertise include peptide-drug conjugates (PDCs) and long-acting peptide formulations. Peidu Bio aims to address unmet medical needs through the design of highly specific and stable peptide candidates. The company is headquartered in the Hefei High-tech Zone and has received backing from regional venture capital firms. Its technology platform focuses on improving the bioavailability and half-life of peptide drugs, including the development of oral delivery systems.